| 6.93 -0.15 (-2.12%) | 06-09 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.58 | 1-year : | 9.37 |
| Resists | First : | 7.35 | Second : | 8.02 |
| Pivot price | 7.02  |
|||
| Supports | First : | 6.26 | Second : | 5.2 |
| MAs | MA(5) : | 7.09 |
MA(20) : | 6.91 |
| MA(100) : | 5.8 |
MA(250) : | 6.97 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 42.3 |
D(3) : | 47.5 |
| RSI | RSI(14): 52.1 |
|||
| 52-week | High : | 9.77 | Low : | 4.4 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ TDOC ] has closed above bottom band by 44.4%. Bollinger Bands are 32.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 7.34 - 7.37 | 7.37 - 7.4 |
| Low: | 6.65 - 6.69 | 6.69 - 6.73 |
| Close: | 6.86 - 6.94 | 6.94 - 6.99 |
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
Sat, 06 Jun 2026
Teladoc Health, Inc. Stock 12‑Month Price Target Cut to $7.05 - TradingView
Fri, 05 Jun 2026
Here's Why Investors Should Hold on to Teladoc Health Stock for Now - Yahoo Finance
Fri, 05 Jun 2026
Teladoc Health (TDOC) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Fri, 05 Jun 2026
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Sahm
Thu, 04 Jun 2026
Insider Sell: Fernando Rodrigues Sells 9,572 Shares of Teladoc H - GuruFocus
Thu, 28 May 2026
$89 virtual care visits now offered through Walmart’s Better Care - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 181 (M) |
| Shares Float | 179 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 81.7 (%) |
| Shares Short | 26,510 (K) |
| Shares Short P.Month | 29,710 (K) |
| EPS | -0.98 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.76 |
| Profit Margin | -6.9 % |
| Operating Margin | -8 % |
| Return on Assets (ttm) | -3.2 % |
| Return on Equity (ttm) | -12.4 % |
| Qtrly Rev. Growth | -2.5 % |
| Gross Profit (p.s.) | 9.63 |
| Sales Per Share | 13.9 |
| EBITDA (p.s.) | 0.26 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 288 (M) |
| Levered Free Cash Flow | 208 (M) |
| PE Ratio | -7.15 |
| PEG Ratio | 0 |
| Price to Book value | 0.89 |
| Price to Sales | 0.49 |
| Price to Cash Flow | 4.34 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|